Featured
Who's been named a top employer?
Judged on leadership, engagement, communication and employee benefits this Big Pharma has taken home a prestigious Australian HR award
Featured
Second pharma joins Medicines Australia
Another company has joined Medicines Australia as a Class 1 Member this month, with its ANZ chief revealing why it is a pivotal time for industry to speak up
Industry & Companies
Significant job cuts hit pharma, with ANZ GM let go
ANZ General Manager among those being let go as “overlapping roles” are made redundant following a recent buyout
Industry & Companies
$50K research prize up for grabs
Eight finalists tackling some of the most pressing challenges in health and medicine are in the running for funding to boost their research
Regulation & Legal
'Faster acting' claim lands in Federal Court
A series of ads claiming superiority over a competitor has ruffled feathers, with the companies landing in court despite agreeing to mediation
Jobs
Featured
Ex-Aussie GM wins global promotion
Less than two years after leaving Australia, this former long-time ANZ GM has already won another promotion, stepping into an important role
Industry & Companies
Sanofi exposes critical ‘GP gap’ in Australia
New data being presented by two Sanofi staffers shows that GPs hold the key to unlocking both clinical trial participation and representation across Australia
Industry & Companies
Fertility a workplace issue: Merck survey
Nearly two in three young Australians believe employers should provide greater workplace support for people navigating fertility issues
Industry & Companies
Why Australia can't win against Trump's MFN policy
New number-crunching has revealed that accepting Australia's notoriously low pricing for a medicine would cost a company more than an entire year's worth of local sales for that drug
Latest
Doctors feel the fear but do it anyway
Survey of Aussie GPs finds accuracy and hallucination risk is considered a "major concern" when it comes to AI yet eight in 10 are using it anyway
Featured
Which Big Pharma is changing its name?
One of the world's best known pharmaceutical companies is reportedly changing its name and introducing a new slogan
Industry & Companies
'The Novo Way' marks a new way of working
The company has updated its culture sharpening how it competes, works and delivers in a faster, more competitive market and there's more to come
Regulatory & Reimbursement
Telix lands an FDA three-peat
Meeting a significant unmet need, this approval will provide broad access to a brain imaging product already recognised in international clinical guidelines
Latest
Never heard of it: disease gap exposed
Pharma commissioned survey reveals low awareness about this chronic disease with symptoms often mistaken as stress associated with 'everyday living'
Regulation & Legal
Fake Lilly drug causes serious side effect
An Australian patient suffered a torn oesophagus after using the counterfeit, which contained eight times the active ingredient used in a popular drug, sponsored by a rival company
Leadership & People
Is Medical Affairs the 'Jan Brady' of pharma?
The MAPA Medical Affairs Summit was told MA is like the 'middle child' of pharma in a robust debate about how best the function can unleash its true potential
Regulatory & Reimbursement
$113M Novartis drug under threat
Among a raft of medicines added to the ARTG last week is the first generic of a Novartis drug that earned $113 million in pre-rebate PBS benefits over the past year.
Featured
GM ANZ role up for grabs
Pharma launches a recruitment drive to find the company's next leader with a glowing reference from its departing GM
Latest
Funding for CAR-T trials for Aussie kids
The first funding from the Australian Cancer Research Program will assist children and young adults with cancer participate in global CAR-T trials
Latest
Leaders gather for first-ever roundtable
More than 40 leaders gather to accelerate evidence-based action, as diagnoses of gynaecological cancers are set to rise 21 per cent over the next decade
Regulatory & Reimbursement
Who's won an October PBS listing... already?
Nineteen days before the turn of the calendar, the Govt has announced the PBS listing of a new treatment for patients with a debilitating disease
Leadership & People
Another Country Boss departs
After 11 years working for the same Big Pharma and almost four serving on the Board of the industry body, this executive is the latest leadership departure
- Leadership & People Scientists behind Big Pharma drugs gonged
- Leadership & People How to lead without the job title
- Leadership & People Meet ANZ's best Medical Affairs professionals
- Other News US Govt funds access to Aussie drug
- Industry & Companies Company eyes ‘golden decade’
- Industry & Companies Industry body names new leader
- Regulatory & Reimbursement Butler tips more drugs to follow the 'Beast’
- Jobs & Workplace Global boss lands top Aussie role
- Industry & Companies On the edge: Here comes the $550B cliff fall
- Jobs & Workplace Open: Netflix-style library for Medical Affairs
